HOME >> BIOLOGY >> NEWS
Journal of Nuclear Medicine publishes NCI-sponsored guidelines for using FDG PET

Reston, Va.--Publication of consensus recommendations for the use of positron emission tomography (PET) imaging--with the radiotracer fluorodeoxyglucose (FDG)--in National Cancer Institute trials will go a long way in helping physicians and scientists determine ways to manage cancer and promote drug development in the future. The recommendations, published in the June issue of the Journal of Nuclear Medicine, focus on the practical aspects of FDG PET (patient preparation; image acquisition, reconstruction and analysis; and quality assurance) and provide a valuable reference for incorporating PET into clinical trials.

"There should be less variability in the performance of FDG PET in clinical trials by enacting these recommendations," explained principal author Lalitha K. Shankar, NCI medical officer at the Cancer Imaging Program. "This would help speed the evaluation of FDG PET as a biomarker. If FDG PET, as is hoped, proves to be a useful biomarker in certain cancers--such as lymphoma, lung and breast cancer among others--this could potentially result in shorter clinical trials in these malignancies and improved therapy for patients with these cancers," she said. These guidelines, drafted by PET experts at various universities and institutes in the United States and abroad, represent a step toward qualifying FDG PET as a biomarker or biologic indicator to assess cancer treatment response.

"To date, there has been no significant agreement on the best methodology for obtaining or analyzing 18F-FDG PET. Standard protocols needed to be developed so that data about the effectiveness of FDG PET as an indicator of treatment response in patients could be collected and compared," Shankar added. Publication of the consensus recommendations is the culmination of attempts to reach agreement between physician and scientist members of the imaging community on certain basic issues regarding the acquisition and analysis of these scans, she said.


'"/>

Contact: Maryann Verrillo
mverrillo@snm.org
703-708-9000
Society of Nuclear Medicine
29-Jun-2006


Page: 1 2

Related biology news :

1. News tips from the Journal of Neuroscience
2. News tips from the Journal of Neuroscience
3. News tips from the Journal of Neuroscience
4. News tips from the Journal of Neuroscience
5. Tips from the Journals of the American Society for Microbiology
6. Journalists can register now for ECCO 14 -- the European Cancer Conference
7. Journal of Alzheimers Disease achieves significant impact factor
8. News tips from the Journal of Neuroscience
9. Highlights from the July 2007 Journal of the American Dietetic Association
10. News tips from the Journal of Neuroscience
11. Journal of Nuclear Medicines impact grows, remains consistently high over past 5 years

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/27/2019)... (PRWEB) , ... August 27, 2019 , ... ... company, announced today new opportunities to improve genetic testing guidelines. In the largest ... improve the guidelines to identify more at-risk patients. , Clinicians use guidelines ...
(Date:8/23/2019)... ... August 22, 2019 , ... R121 ... their acquisition in June of 2018. Along with the name change, this rebranding ... “Our goal was to create a cohesive brand that blended our core foundation ...
(Date:8/19/2019)... ... August 19, 2019 , ... Since the microscope was first ... dimensional slices which are placed on microscope slides, stained and visualized by a ... features such as vasculature and thus researchers in the last few years have ...
Breaking Biology News(10 mins):
(Date:9/11/2019)... ... 10, 2019 , ... An upcoming episode of Advancements with ... genome sequencing analysis. Check your local listings for more information. , Advancements will ... Consulting and will explore its revolutionary pathogenic DNA analysis technology, which predicts in ...
(Date:9/9/2019)... ... September 09, 2019 , ... Visikol CEO Dr. Michael Johnson recently gave a ... best to characterize 3D cell culture models. The inherent problem of characterizing 3D cell ... opaque to image through and therefore traditional wide-field or even confocal microscopy only tells ...
(Date:9/8/2019)... ... 05, 2019 , ... Spartan Bioscience, the leader in on-demand ... Shopify, has been named Chief Financial Officer. , Spartan has also named ... advisors. Additionally, Spartan has hired Steve Edgett as Executive Vice President to lead ...
(Date:9/2/2019)... and LIÉGE, Belgium (PRWEB) , ... September 02, ... ... solutions for epigenetics research and in vitro diagnostics, has launched the industry’s first ... uncover the underlying biological meaning of epigenetic data and other data types. , ...
Breaking Biology Technology:
Cached News: